Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Buy
1,633
+65
+4% +$12.4K 0.01% 847
2026
Q1
$287K Buy
+1,568
New +$289K 0.01% 879
2024
Q4
Sell
-1,692
Closed -$328K 1032
2024
Q3
$328K Sell
1,692
-57
-3% -$11.9K 0.02% 673
2024
Q2
$405K Sell
1,749
-105
-6% -$22.8K 0.03% 537
2024
Q1
$400K Buy
+1,854
New +$434K 0.02% 626

Other funds holding BIIB

PFG Investments's BIIB Position: Q2 2026 in Review

PFG Investments increased its Biogen (BIIB) stake by 4.1% in Q2 2026, buying an estimated $12.4K and bringing the position to 1,633 shares worth $353K. The position accounts for 0.01% of the portfolio, ranked #847.

PFG Investments first reported a position in BIIB in Q1 2024 and has held it in 5 quarters since. The position peaked at $405K in Q2 2024. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • PFG Investments held 1,633 shares of Biogen worth $353K as of Q2 2026.
  • PFG Investments bought 65 Biogen shares in Q2 2026, an estimated $12.4K.
  • Biogen made up 0.01% of PFG Investments's portfolio in Q2 2026, its #847 holding.
  • PFG Investments first reported a position in Biogen in Q1 2024 and has held it in 5 quarters since.
  • PFG Investments's Biogen position peaked at $405K in Q2 2024.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.